These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 11243219

  • 1. [Involvement of cytochrome P4503A in the monohydroxylation of ring A of praziquantel in rat liver microsomes].
    Zhang YJ, Quan YZ.
    Yao Xue Xue Bao; 1997; 32(1):5-10. PubMed ID: 11243219
    [Abstract] [Full Text] [Related]

  • 2. Erythromycin as a specific substrate for cytochrome P4503A isozymes and identification of a high-affinity erythromycin N-demethylase in adult female rats.
    Zhang XJ, Thomas PE.
    Drug Metab Dispos; 1996 Jan; 24(1):23-7. PubMed ID: 8825186
    [Abstract] [Full Text] [Related]

  • 3. In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle.
    Zweers-Zeilmaker WM, Van Miert AS, Horbach GJ, Witkamp RF.
    Res Vet Sci; 1999 Feb; 66(1):51-5. PubMed ID: 10088712
    [Abstract] [Full Text] [Related]

  • 4. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.
    Zerilli A, Ratanasavanh D, Lucas D, Goasduff T, Dréano Y, Menard C, Picart D, Berthou F.
    Chem Res Toxicol; 1997 Oct; 10(10):1205-12. PubMed ID: 9348445
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
    Cook CS, Hauswald C, Oppermann JA, Schoenhard GL.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):1-7. PubMed ID: 8331551
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The roles of CYP3A and CYP2B isoforms in hepatic bioactivation and detoxification of the pyrrolizidine alkaloid senecionine in sheep and hamsters.
    Huan JY, Miranda CL, Buhler DR, Cheeke PR.
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):229-35. PubMed ID: 9707499
    [Abstract] [Full Text] [Related]

  • 10. Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine.
    Chang T, Levine M, Bandiera SM, Bellward GD.
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1441-9. PubMed ID: 1545403
    [Abstract] [Full Text] [Related]

  • 11. [Study on metabolism of tetramethylpyrazine in system of rat liver microsomes].
    Kuang XD, Li XH, Xiong YQ.
    Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1971-5. PubMed ID: 17348193
    [Abstract] [Full Text] [Related]

  • 12. Ethylmorphine N-demethylase activity as a marker for cytochrome P450 CYP3A activity in rat hepatic microsomes.
    Amacher DE, Schomaker SJ.
    Toxicol Lett; 1998 Jan 31; 94(2):115-25. PubMed ID: 9574808
    [Abstract] [Full Text] [Related]

  • 13. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L, Rosato A, Napoli E, Sola F, Geroni C, Floreani M, Zanovello P.
    Cancer Res; 2000 Jun 15; 60(12):3232-8. PubMed ID: 10866316
    [Abstract] [Full Text] [Related]

  • 14. Strain differences in CYP3A-mediated C-8 hydroxylation (1,3,7-trimethyluric acid formation) of caffeine in Wistar and Dark Agouti rats. Rapid metabolism of caffeine in debrisoquine poor metabolizer model rats.
    Morita K, Maeda Y, Masuda M, Kazusaka A, Imaoka S, Funae Y, Fujita S.
    Biochem Pharmacol; 1998 May 01; 55(9):1405-11. PubMed ID: 10076532
    [Abstract] [Full Text] [Related]

  • 15. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA, Syrek M, Ryłko Z, Wójcikowski J.
    Pol J Pharmacol; 2001 May 01; 53(4):351-7. PubMed ID: 11990081
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
    Yumoto R, Murakami T, Sanemasa M, Nasu R, Nagai J, Takano M.
    Drug Metab Dispos; 2001 Feb 01; 29(2):145-51. PubMed ID: 11159804
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractions.
    Fitzpatrick JL, Ripp SL, Smith NB, Pierce WM, Prough RA.
    Arch Biochem Biophys; 2001 May 15; 389(2):278-87. PubMed ID: 11339818
    [Abstract] [Full Text] [Related]

  • 18. Protection of ethanol-mediated acetaminophen hepatotoxicity by triacetyloleandomycin, a specific inhibitor of CYP3A.
    Kostrubsky VE, Szakacs JG, Jeffery EH, Woods SG, Bement WJ, Wrighton SA, Sinclair PR, Sinclair JF.
    Ann Clin Lab Sci; 1997 May 15; 27(1):57-62. PubMed ID: 8997458
    [Abstract] [Full Text] [Related]

  • 19. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
    Nebbia C, Ceppa L, Dacasto M, Carletti M, Nachtmann C.
    Drug Metab Dispos; 1999 Sep 15; 27(9):1039-44. PubMed ID: 10460804
    [Abstract] [Full Text] [Related]

  • 20. Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe.
    Chauret N, Tremblay N, Lackman RL, Gauthier JY, Silva JM, Marois J, Yergey JA, Nicoll-Griffith DA.
    Anal Biochem; 1999 Dec 15; 276(2):215-26. PubMed ID: 10603245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.